JP2022513372A5 - - Google Patents

Info

Publication number
JP2022513372A5
JP2022513372A5 JP2021547039A JP2021547039A JP2022513372A5 JP 2022513372 A5 JP2022513372 A5 JP 2022513372A5 JP 2021547039 A JP2021547039 A JP 2021547039A JP 2021547039 A JP2021547039 A JP 2021547039A JP 2022513372 A5 JP2022513372 A5 JP 2022513372A5
Authority
JP
Japan
Prior art keywords
item
polypeptide
acid sequence
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021547039A
Other languages
English (en)
Japanese (ja)
Other versions
JP7672340B2 (ja
JP2022513372A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/057017 external-priority patent/WO2020081988A1/en
Publication of JP2022513372A publication Critical patent/JP2022513372A/ja
Publication of JP2022513372A5 publication Critical patent/JP2022513372A5/ja
Priority to JP2025041321A priority Critical patent/JP2025085740A/ja
Application granted granted Critical
Publication of JP7672340B2 publication Critical patent/JP7672340B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021547039A 2018-10-19 2019-10-18 シアリルルイスaを標的とするキメラ抗原受容体およびその使用 Active JP7672340B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025041321A JP2025085740A (ja) 2018-10-19 2025-03-14 シアリルルイスaを標的とするキメラ抗原受容体およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862748198P 2018-10-19 2018-10-19
US62/748,198 2018-10-19
PCT/US2019/057017 WO2020081988A1 (en) 2018-10-19 2019-10-18 Chimeric antigen receptor targeting sialyl lewis a and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025041321A Division JP2025085740A (ja) 2018-10-19 2025-03-14 シアリルルイスaを標的とするキメラ抗原受容体およびその使用

Publications (3)

Publication Number Publication Date
JP2022513372A JP2022513372A (ja) 2022-02-07
JP2022513372A5 true JP2022513372A5 (cg-RX-API-DMAC7.html) 2022-10-19
JP7672340B2 JP7672340B2 (ja) 2025-05-07

Family

ID=70283157

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021547039A Active JP7672340B2 (ja) 2018-10-19 2019-10-18 シアリルルイスaを標的とするキメラ抗原受容体およびその使用
JP2025041321A Pending JP2025085740A (ja) 2018-10-19 2025-03-14 シアリルルイスaを標的とするキメラ抗原受容体およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025041321A Pending JP2025085740A (ja) 2018-10-19 2025-03-14 シアリルルイスaを標的とするキメラ抗原受容体およびその使用

Country Status (5)

Country Link
US (1) US20210246221A1 (cg-RX-API-DMAC7.html)
EP (1) EP3867279A4 (cg-RX-API-DMAC7.html)
JP (2) JP7672340B2 (cg-RX-API-DMAC7.html)
CN (1) CN113454115B (cg-RX-API-DMAC7.html)
WO (1) WO2020081988A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105764526B (zh) * 2013-08-26 2020-12-15 生物技术研发公司 编码抗唾液酸化路易斯a抗原的人抗体的核酸
WO2021105989A1 (en) * 2019-11-26 2021-06-03 Ramot At Tel-Aviv University Ltd. Chimeric antigen receptor to carbohydrate antigens
WO2021105988A1 (en) 2019-11-26 2021-06-03 Ramot At Tel-Aviv University Ltd. Antibodies to carbohydrate antigens
CN112457416B (zh) * 2020-12-15 2021-08-17 吴菲 一种靶向bcma的嵌合抗原受体(car)及其应用
CN115876993B (zh) * 2022-11-17 2024-10-15 沈阳农业大学 基于生物膜干涉技术检测病原生物凝集素与唾液酸乳糖亲和力方法的建立
CN117092046B (zh) * 2023-08-03 2024-03-08 首都医科大学附属北京安定医院 一种检测精神病患者口腔是否藏匿药物的方法
TW202615101A (zh) * 2024-06-06 2026-04-16 德商拜恩技術股份公司 Ca19-9結合分子

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105764526B (zh) * 2013-08-26 2020-12-15 生物技术研发公司 编码抗唾液酸化路易斯a抗原的人抗体的核酸
CN122399016A (zh) * 2014-03-15 2026-07-17 诺华股份有限公司 使用嵌合抗原受体治疗癌症
WO2015188141A2 (en) * 2014-06-06 2015-12-10 Memorial Sloan-Kettering Cancer Ceneter Mesothelin-targeted chimeric antigen receptors and uses thereof
DK3227339T3 (da) * 2014-12-05 2022-01-10 Memorial Sloan Kettering Cancer Center Kimæriske antigenreceptorer rettet mod g-protein-koblet receptor og anvendelser deraf
CN113698497A (zh) * 2014-12-05 2021-11-26 纪念斯隆-凯特琳癌症中心 靶向b-细胞成熟抗原的嵌合抗原受体及其用途
GB201515094D0 (en) * 2015-08-25 2015-10-07 Univ Nottingham Sialyl-di-lewis a as expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto
CA3002097A1 (en) * 2015-11-12 2017-05-18 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
US20190112380A1 (en) * 2016-03-29 2019-04-18 University Of Southern California Chimeric antigen receptors targeting cancer
IL326873A (en) * 2017-12-29 2026-04-01 Memorial Sloan Kettering Cancer Center Enhanced chimeric antigen receptors and uses thereof

Similar Documents

Publication Publication Date Title
TWI800506B (zh) 免疫結合物
TWI780140B (zh) 免疫結合物
JP7573441B2 (ja) ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法
KR102411571B1 (ko) 치료제
JP2022109915A (ja) Cd80バリアント免疫調節タンパク質およびその使用
JP7853916B2 (ja) 免疫複合体
JP2017535264A (ja) 阻害性キメラ抗原受容体
US11447570B2 (en) Binding unit targeting fibroblast activation protein α and application thereof
CN114502188B (zh) 人工免疫监视嵌合抗原受体及其表达细胞
JP2022527081A5 (cg-RX-API-DMAC7.html)
JP7812549B2 (ja) 人工免疫監視キメラ抗原受容体(ai-car)及びそれを発現する細胞
JP2022548112A5 (cg-RX-API-DMAC7.html)
CN120548192A (zh) 免疫缀合物
JP2024534783A5 (cg-RX-API-DMAC7.html)
IL324341A (en) Methods of using il-18 fusion proteins
CN114685659B (zh) Cd22特异性人源化抗体及利用其的嵌合抗原受体
JP2021530238A5 (cg-RX-API-DMAC7.html)
JP2024535740A5 (cg-RX-API-DMAC7.html)
JP2024532486A5 (cg-RX-API-DMAC7.html)
JP2022550120A5 (cg-RX-API-DMAC7.html)
US20250041419A1 (en) Modified Cytotoxic T Cells and Methods of Use Thereof
HK40123337A (en) Immunoconjugates
Burns The Major Clinical Components of Cancer Immunotherapy (Modulating Cell-Mediated Immune Mechanisms)
Bridgeman et al. T-Bodies: Antibody-Based Engineered T-Cell Receptors
HK40074322B (en) Artificial immunosurveillance chimeric antigen receptor and cells expressing the same